The Integrity Tests: Choosing Diffusive Airflows of Bubble Points

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-01-2004
Volume 2004 Supplement
Issue 7

This article critiques the diffusive-airflow and bubble-point tests for their comparative suitability for integrity testing in pharmaceutical processes.

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Related Content